SI21236A - Postopek kristalizacije losartan kalija - Google Patents

Postopek kristalizacije losartan kalija Download PDF

Info

Publication number
SI21236A
SI21236A SI200120042A SI200120042A SI21236A SI 21236 A SI21236 A SI 21236A SI 200120042 A SI200120042 A SI 200120042A SI 200120042 A SI200120042 A SI 200120042A SI 21236 A SI21236 A SI 21236A
Authority
SI
Slovenia
Prior art keywords
losartan
potassium
acetone
methanol
losartan potassium
Prior art date
Application number
SI200120042A
Other languages
English (en)
Slovenian (sl)
Inventor
Ramashankar
Ravinder Vennapu Reddy
Meenakshisunderam Sivakumaran
Vijay Kumar Handa
Original Assignee
Aurobindo Pharma Limited
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Aurobindo Pharma Limited filed Critical Aurobindo Pharma Limited
Publication of SI21236A publication Critical patent/SI21236A/sl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/10—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing aromatic rings
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02P—CLIMATE CHANGE MITIGATION TECHNOLOGIES IN THE PRODUCTION OR PROCESSING OF GOODS
    • Y02P20/00—Technologies relating to chemical industry
    • Y02P20/50—Improvements relating to the production of bulk chemicals
    • Y02P20/55—Design of synthesis routes, e.g. reducing the use of auxiliary or protecting groups

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
SI200120042A 2001-05-18 2001-11-20 Postopek kristalizacije losartan kalija SI21236A (sl)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IN403CH2001 2001-05-18
PCT/IN2001/000205 WO2002094816A1 (fr) 2001-05-18 2001-11-20 Procede de cristallisation du losartan potassium

Publications (1)

Publication Number Publication Date
SI21236A true SI21236A (sl) 2003-12-31

Family

ID=11097003

Family Applications (1)

Application Number Title Priority Date Filing Date
SI200120042A SI21236A (sl) 2001-05-18 2001-11-20 Postopek kristalizacije losartan kalija

Country Status (6)

Country Link
EP (1) EP1294712A1 (fr)
JP (1) JP2004520446A (fr)
BG (1) BG107478A (fr)
SI (1) SI21236A (fr)
SK (1) SK722003A3 (fr)
WO (1) WO2002094816A1 (fr)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030135041A1 (en) 2002-01-04 2003-07-17 Orchid Chemicals & Pharmaceuticals Limited, India Synthesis of ceftiofur intermediate
AU2003278422A1 (en) * 2002-10-31 2004-05-25 Ranbaxy Laboratories Limited Amorphous form of losartan potassium
ITMI20030328A1 (it) * 2003-02-25 2004-08-26 Dinamite Dipharma S P A In Forma A Bbreviata Diph Polimorfi di losartan potassio e procedimento per la loro preparazione.
WO2004076442A1 (fr) * 2003-02-28 2004-09-10 Ranbaxy Laboratories Limited Polymorphes de losartan
WO2004087691A1 (fr) * 2003-04-03 2004-10-14 Ipca Laboratories Limited Procede de synthese de losartan potassique
US7345071B2 (en) 2003-05-07 2008-03-18 Ipca Laboratories Limited Process for the synthesis of Losartan potassium
ATE482950T1 (de) * 2003-08-27 2010-10-15 Zentiva Ks Verfahren zur entfernung der triphenylmethanschutzgruppe
ITMI20032472A1 (it) * 2003-12-16 2005-06-17 Dinamite Dipharma S P A In Forma A Bbreviata Diph Procedimento per la preparazione di losartan potassio cristallino
EP1709034A2 (fr) * 2004-01-06 2006-10-11 IPCA Laboratories Limited Procede ameliore de synthese du losartan potassique
EP1713795A2 (fr) 2004-02-11 2006-10-25 Teva Pharmaceutical Industries Ltd. Polymorphes de candesartan cilexetil
EP1729766A1 (fr) * 2004-03-01 2006-12-13 LEK Pharmaceuticals D.D. Formulation pharmaceutique
MXPA06012702A (es) * 2004-05-05 2007-04-02 Teva Pharma Preparacion de candesartan cilexetil de alta pureza.
WO2010046804A2 (fr) * 2008-10-21 2010-04-29 Alembic Limited Procédé de préparation du losartan potassium forme i

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5138069A (en) * 1986-07-11 1992-08-11 E. I. Du Pont De Nemours And Company Angiotensin II receptor blocking imidazoles
ES2203614T3 (es) * 1991-11-18 2004-04-16 E.I. Du Pont De Nemours And Company Intermedios de acido tetrazolilfenilboronico para la sintesis de antagonistas de los receptores de aii.
CN1101393C (zh) * 1996-10-29 2003-02-12 麦克公司 芦沙坦的结晶方法
HU222773B1 (hu) * 2000-04-21 2003-10-28 Richter Gedeon Vegyészeti Gyár Rt. Eljárás egy ismert tetrazolszármazék előállítására

Also Published As

Publication number Publication date
JP2004520446A (ja) 2004-07-08
SK722003A3 (en) 2003-12-02
BG107478A (bg) 2004-01-30
EP1294712A1 (fr) 2003-03-26
WO2002094816A1 (fr) 2002-11-28

Similar Documents

Publication Publication Date Title
KR100442717B1 (ko) 세프디니르의 결정성 아민 염
SI21236A (sl) Postopek kristalizacije losartan kalija
EP1274702B1 (fr) Procede de synthese d'un derive connu du tetrazol
US5101040A (en) Process for the industrial preparation of 4-chloro-3-sulfamoyl-n-(2,3-dihydro-2-methyl-1h-indol-1-yl)benzamide
JP2004520446A5 (fr)
US20090069306A1 (en) Process for producing highly pure midazolam and salts thereof
SU558644A3 (ru) Способ получени имидазолов или их солей
US4537900A (en) Cimetidine Z, a new crystal modification of cimetidine
US6350880B1 (en) Crystalline or crystallized acid addition salt of losartan and purification method of losartan
SK285138B6 (sk) Spôsob výroby farmaceuticky prijateľnej soli klavulanovej kyseliny
EP0644192A1 (fr) Procédé pour la préparation d'un dérivé de la benzothiadiazole
EP0500952B1 (fr) Procede pour produire un heterocycle azote
EP3722285B1 (fr) Procédé de préparation de mirabegron énacarbile
KR100702429B1 (ko) 티에나마이신으로 부터 정제된 결정성 이미페넴의 제조 방법
US4477677A (en) Process for the preparation of 1-(4-chlorobenzoyl)-5-methoxy-2-methyl-3-indoleacetoxyacetic acid
EP0001266B1 (fr) Sulfamates substitués de 2-aminométhyl-phényle, leur procédé de préparation et compositions pharmaceutiques les contenant
US6916935B2 (en) Losartan potassium synthesis
US20230089434A1 (en) Synthesis of nirogacestat
US7345071B2 (en) Process for the synthesis of Losartan potassium
WO2023100110A1 (fr) Procédé de préparation de brivaracétam
CN117858866A (zh) 用于制备色胺衍生物的方法
US6235775B1 (en) Acetone adduct of fungicidal V-28-3M
JPH10195075A (ja) Ｚ−バラシクロビルの製造方法
JPS6221348B2 (fr)
JPH0368571A (ja) Ｎ―置換２、４、６―トリイミノトリアジン誘導体の製造方法

Legal Events

Date Code Title Description
IF Valid on the event date
KO00 Lapse of patent

Effective date: 20050822